Docetaxel for prostate cancer: Best timing and right patient

Date 09 October 2016
Event ESMO 2016 Congress
Session Multimodality treatment for hormone-naïve metastatic prostate cancer
Topics Anticancer agents
Prostate Cancer
Therapy
Biological Therapy
Presenter Nick James
Authors N. James
  • Cancer And Genomic Sciences, University of Birmingham, B15 2TT - Birmingham/GB